Automation of Sample Preparation for Accurate and Scalable Quantification and Characterization of Biotherapeutic Proteins Using the Agilent AssayMAP Bravo Platform

Importance of the Topic

Biotherapeutic proteins are a cornerstone of modern drug discovery and development, yet traditional manual sample preparation for LC/MS analysis can be laborious, low-throughput and prone to variability. An automated, scalable workflow reduces hands-on time, improves reproducibility, and accelerates decision-making, enabling rapid characterization and quantification of candidate molecules in high-value bioprocessing and quality control environments.

Study Objectives and Overview

This work evaluates the Agilent AssayMAP Bravo platform in two common biotherapeutic protein workflows:

• Peptide quantification: parallel purification of 96 antibody samples using Protein G cartridges, enzymatic digestion, and C18 cleanup with subsequent LC/MS analysis.
• Sequence coverage characterization: parallel digestion of antibodies with three proteases (trypsin, chymotrypsin, Glu-C) and aggregated LC/MS mapping to achieve near‐complete sequence information for heavy and light chains.

Methodology and Used Instrumentation

The automated workflow integrates three AssayMAP Bravo applications:

• Affinity Purification: PA-W (Protein A) or PG-W (Protein G) cartridges for selective antibody capture, washing and low-volume elution.
• In-Solution Digestion: automated reduction, alkylation, and proteolysis steps in parallel.
• Peptide Cleanup: C18 reversed-phase cartridges for desalting and concentration of peptides.

Key instrumentation:

• Agilent AssayMAP Bravo liquid handling platform with 96-channel syringe head.
• Agilent 1290 Infinity and 1260 Bio-inert LC systems.
• Agilent 6550 iFunnel Q-TOF mass spectrometer with Dual Jet Stream ESI.

Main Results and Discussion

Quantitative recovery studies demonstrated linear antibody capture over 1–100 µg loads, with recoveries >90% and CVs <5%. Minimal elution volumes (<10 µL with 5% acetic acid) were achieved, preserving sample concentration for downstream analysis. Reproducibility across 96‐well plates showed CVs <2% for affinity capture and 5–8% for peptide quantification based on extracted ion chromatogram peak areas of six proteotypic peptides.

Sequence coverage experiments revealed that combining data from trypsin, chymotrypsin and Glu-C digests provided 99% coverage of the heavy chain (433 of 439 amino acids) and 100% of the light chain (214 of 214 amino acids). Single-enzyme digests left gaps in regions lacking cleavage sites, underscoring the value of multi‐enzyme workflows.

Practical Benefits and Applications

The fully automated sample prep platform delivers:

• High throughput processing of 8–96 samples in parallel.
• Robust, reproducible recovery and digestion with minimal manual intervention.
• Low elution volumes for compatibility with sensitive LC/MS detection.
• Flexibility to customize buffers, enzymes and cartridge types for diverse biotherapeutic targets.

This approach is ideally suited for candidate screening, process development, QA/QC and regulatory compliance in biopharmaceutical laboratories.

Future Trends and Applications

Anticipated developments include:

• Integration with machine-learning data analysis for real-time quality assessment.
• Expanded cartridge chemistries for PTM mapping, glycoanalysis and intact mass workflows.
• Further miniaturization and integration with microfluidic front ends for single-cell and low-volume studies.
• Automation of orthogonal methods (e.g., size-exclusion, ion exchange) on a unified platform.

Conclusion

The Agilent AssayMAP Bravo platform offers a comprehensive, automated solution for scalable and reproducible biotherapeutic protein sample preparation. By combining affinity capture, parallel digestion and peptide cleanup, it addresses key bottlenecks in LC/MS workflows, delivering quantitative accuracy, high sequence coverage and streamlined operation for modern biopharma research and quality control.

Reference

1. Russell J.D.; et al. Automation for LC/MS Sample Preparation: High Throughput In-Solution Digestion and Peptide Cleanup Enabled by the Agilent AssayMAP Bravo Platform. Agilent Technologies Application Note, 5991-2957EN, 2013.